Clinical Trials Sponsored by Drug Science, UK

Total 170 results

Bod Australia
Drug Science, UK

Completed

Feasibility of Cannabidiol for the Treatment of Long COVID

Long COVID

United Kingdom
Drug Safety Research Unit, Southampton, UK

Completed

Rivaroxaban ACS Specialist Cohort Event Monitoring Study (ROSE ACS)

Acute Coronary Syndrome

United Kingdom
Paion UK Ltd.
PRA Health Sciences

Terminated

Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery

Anesthesia

Germany
Paion UK Ltd.
PRA Health Sciences

Completed

Absolute Oral Bioavailability of Remimazolam

Bioavailability

United States
Paion UK Ltd.
PRA Health Sciences

Completed

A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability

Procedural Sedation

United States
Paion UK Ltd.
PRA Health Sciences

Completed

Oral Remimazolam With and Without Alcohol in Healthy Female Subjects

Safety Issues

United States
Paion UK Ltd.
PRA Health Sciences

Completed

Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users

Abuse, Drug

United States
Professor Saad Shakir
Bayer

Completed

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®). (ROSE)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

United Kingdom
Liverpool John Moores University
Institute of Naval Medicine (UK); CTCRM Lympstone (UK); University of Portsmouth... and other collaborators

Recruiting

Risk Factors for Exertional Heat Illness

Exertional Heat Illness

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited
Alba Science Ltd

Completed

A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects

Healthy

United Kingdom
Manchester Academic Health Science Centre
Erasmus Medical Center; Tommy's; Academy of Medical Sciences, UK

Active, not recruiting

The START Clinic: a Feasibility Study (START)

Pregnancy Complications | Placenta Diseases | Fetal Growth Retardation | Preeclampsia | IVF

United Kingdom
University of Sao Paulo
Academy of Medical Sciences, UK

Completed

Response Predictors of Theta-burst Stimulation for Depression (TBS)

Depression

Brazil
Professor Saad Shakir
Merck Sharp & Dohme LLC

Completed

An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)

Bipolar I Disorder

United Kingdom
Professor Saad Shakir
Merck Sharp & Dohme LLC

Completed

Observational Post-Authorisation Safety Study of Asenapine (Sycrest) (OBSERVA)

Manic Disorder

United Kingdom
Imperial College London
Engineering and Physical Sciences Research Council, UK

Not yet recruiting

Remote Monitoring in Preschool Wheeze

Respiratory Sounds | Wheezing

United Kingdom
Imperial College London
Engineering and Physical Sciences Research Council, UK

Completed

Investigating Outcomes of Lower Limb Trauma

Trauma

United Kingdom
The Leeds Teaching Hospitals NHS Trust
Innovate UK; PinPoint Data Science Ltd.

Suspended

Guide for Prioritisation of Patients for Referral to Breast Clinics

Breast Cancer

United Kingdom
Silverchair Science & Communications, LLC
National Institute on Drug Abuse (NIDA)

Unknown

QuitAdvisorMD: A Point-of-care Tool for Brief Smoking Cessation Interventions

Smoking | Tobacco Use Disorder

United States
Drugs for Neglected Diseases
Quotient Sciences

Completed

Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin

Gonorrhea

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Recruiting

Effects of a Specific Substance in Smokers

Smoking

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)

Opioid Use Disorder | Alcohol Use Disorder

Canada, United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade

HIV | Methamphetamine Abuse

United States
Ensysce Biosciences
National Institute on Drug Abuse (NIDA); Quotient Sciences

Completed

Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (MPAR-101)

Pharmacokinetics

United States
NMP Medical Research Institute
Warwick Research Services (UK) Ltd; Swamigal Trust for Vedic Science, India

Completed

Vedic Medical Astrology in Essential Hypertension

Essential Hypertension

India
National Institute on Drug Dependence, China
National Natural Science Foundation of China

Completed

Incubation of Alcohol Craving During Abstinence

Alcohol Dependence
China Academy of Chinese Medical Sciences
China Food and Drug Administration

Completed

Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke

Acute Stroke

China
Sanjay Gandhi Postgraduate Institute of Medical...
St George's University of London, London, UK

Recruiting

Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

Crohn's Disease

India
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)

Recruiting

Cannabis Edibles Packaging Imagery Experiment

Cannabis Use

United States
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)

Recruiting

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury (CHI)

Inflammation | HIV | Cannabis | Cognition | Neuroimaging

United States
Sunnybrook Health Sciences Centre
Alzheimer's Drug Discovery Foundation; Weston Brain Institute

Recruiting

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients (SARTAN-AD)

Alzheimer's Disease

Canada
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)

Completed

Cannabis Edibles Packaging Descriptors Experiment

Cannabis Use

United States
China Academy of Chinese Medical Sciences
China Food and Drug Administration

Completed

Danhong Injection in the Treatment of Acute Ischemic Stroke

Acute Stroke

China
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)

Completed

Project 1, Study 2: The Combined Impact of Nicotine Replacement and Spectrum Cigarettes

Cigarette Smoking

United States
China Academy of Chinese Medical Sciences
China Food and Drug Administration

Completed

Danhong Injection in the Treatment of Unstable Angina Pectoris

Unstable Angina Pectoris

China
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)

Recruiting

Organization-level Youth Engagement Approach for Substance Misuse Prevention

Substance Use | Opioid Use | Drug Use | Substance Misuse

United States
Sunnybrook Health Sciences Centre
Alzheimer's Drug Discovery Foundation; Weston Brain Institute

Recruiting

Nabilone for Agitation Blinded Intervention Trial (NAB-IT)

Alzheimer Disease | Agitation

Canada
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)

Withdrawn

The Impact of E-liquid Nicotine Content on Reinforcement in Current Smokers

Tobacco Use
Wake Forest University Health Sciences
National Institute on Drug Abuse (NIDA)

Completed

Project 2: Strategies for Reducing Nicotine Content in Cigarettes

Tobacco Smoking | Nicotine Dependence

United States
China Academy of Chinese Medical Sciences
China Food and Drug Administration

Completed

Danhong Injection in the Treatment of Chronic Stable Angina

Chronic Stable Angina

China
Woundchek Laboratories BV
Innovate UK; Pennine Care NHS Foundation Trust; Greater Manchester Academic Health...

Completed

WOUNDCHEK Bacterial Status Benefits Evaluation

Chronic Wounds

United Kingdom
Dandelion Science
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Visual Stimulation for Pain Relief

Pain

United States
University of North Texas Health Science Center
National Institute on Drug Abuse (NIDA)

Completed

Motivational Assessment Program to Initiate Treatment (MAPIT)

Substance-Related Disorders

United States
ProDigest
University Ghent; Maastricht University; Embria Health Sciences; Drug Research...

Completed

Clinical Evaluation of the Effects of EpiCor on Digestive Comfort

Constipation | Gastrointestinal Discomfort
Oklahoma State University Center for Health Sciences
National Institute of Drug Abuse

Recruiting

Semaglutide Therapy for Alcohol Reduction - Tulsa (STAR-T)

Alcohol Use Disorder

United States
Drugs for Neglected Diseases
Gilead Sciences; Paladin Labs Inc.

Completed

Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa

Primary Visceral Leishmaniasis

Kenya, Sudan
Aaron J. Janowsky
National Institute on Drug Abuse (NIDA)

Withdrawn

"The Evaluation of Stimulant Withdrawal" (MARC)

Anxiety | Relapse | Substance Addiction

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo

Cocaine-Related Disorders

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals

Cocaine-Related Disorders

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Medications for Stopping Cocaine Dependence and Preventing Relapse

Cocaine-Related Disorders | Cocaine Abuse

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder

Cocaine Use Disorder

United States

Clinical Trials Sponsored by Drug Science, UK

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations